Stockreport

Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF The study found that nearly two-thirds of patients treated with icotrokinra achieved significant skin clearance, with 64.7% achieving clear or almost clear skin and 49.6 [Read more]